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Abstract
Introduction: Adverse progression of autoimmune diseases is linked to the
dysregulation of cytokines. In this regard we investigated the role of 
4-nonylphenol (4-NP), as a potential contributing factor in the development of
immune diseases and compared it to estrogens actions since 4-NP may work
via estrogen processes. 
Material and methods: The study made cytokine level expression changes in
U937 cells by microarray technology coupled to RT PCR as a validating technique. 
Results: It was determined that 4-NP significantly up-regulated proinflammatory
cytokine expression (toll-like-receptor [TLR]-6, TLR-10, interleukin [IL]-1, IL-5, 
IL-6, IL-17C, IL-23A, IL-8RB, IL-receptor-associated-kinase [IRAK-2], tumor-necrosis-
factor-receptor [TNFR]-5, and TNFR-10). Estrogen caused insignificant increases
but the changes parralelled that of 4-NP . Simultaneously, 4-NP down-regulated
the expression of anti-inflammatory cytokines (IL-4 and IL-10), while estrogen
up-regulated them. 
Conclusions: 4-Nonylphenol may initiate its toxic effects and pose a risk to
autoimmunity-prone individuals by eliciting effects up to 4 times more potent
than estrogen. Overall, exposure to 4-NP may contribute to autoimmune
susceptibility and/or exacerbate existing autoimmune conditions by dys  -
regulating normal expression of cytokines.
Key words: 4-nonylphenol (4-NP), estrogen, interleukins, cytokines, proinflammatory,
environmental toxins.
Introduction
Autoimmune diseases represent the 3rd most common major illnesses
in the United States. Although there are 80 different forms of known
autoimmune diseases, all are characterized by a “confused” immune
response that self-attacks its own cells and organs. Currently, around 23.5
million Americans (1 in 12) are affected by at least one autoimmune
disease, 78% of whom are women , suggesting an estrogen involvement. 
Estrogen, a major gonadal steroid that serves as a naturally occurring
chemical messenger, has been shown to directly regulate the immune
response, due to the presence of estrogen receptors on lymphocytes [1].
Thus, environmental factors that affect estrogen-related processes in the
body may also play consequential roles in eliciting autoimmune disease
[2-5]. Accordingly, evidence suggests that recently developed and now
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ubiquitous industrial estrogens are possible
contributors to autoimmune risk [6-9].
Xenoestrogens are man-made, endocrine-
disrupting chemicals that specifically mimic
estrogen-regulated processes in the body. Through
environmental exposures, they alter an organism’s
ability to maintain homeostasis, especially those
controlled by estrogen [10]. One of the fastest
growing xenoestrogens worldwide is 4-nonylphenol
(4-NP) [11]. 4-Nonylphenol is the biodegradation
product of nonylphenol ethoxylates (NPEOs) [12].
Since NPEOs are nonionic surfactants, they are
typically used to manufacture domestic liquid
detergents, cosmetics, industrial cleaners, paints,
and pesticides [13, 14]. After 4-NP exits wastewater
plants via sewage effluents, humans are exposed
to 4-NP by drinking contaminated water, breathing
contaminated air, contacting tainted sediments,
and/or ingesting contaminated food, plants and
animals [15-18].
Proinflammatory cytokines, while initially pro  -
tective, may act to worsen disease, while anti  -
inflammatory cytokines serve to reduce inflam  -
mation and promote healing [19]. Autoimmune
diseases are triggered by a dysregulation of
cytokines – too many proinflammatory and too few
anti-inflammatory cytokines are expressed, causing
the immune system to function uncontrollably [20,
21]. Interestingly, in 2004, Lee et al. demonstrated
that 4-octylphenol (OP), a different xenoestrogen,
significantly inhibited the activation of the anti-
inflammatory interleukin-4 (IL-4) gene in mouse 
T-cells [22]. Yano et al. (2003) reported similar
results by showing that OP inhibited the production
of IL-4 in mouse spleen cells [23]. This suggests that
OP, as well as other xenoestrogens, may play
a negative role in the immune system by inhibiting
the production of anti-inflammatory, pro-healing
cytokines. In the present study we investigated the
effects of 4-NP and estrogen on proinflammatory
and anti-inflammatory cytokine gene expression
using the well established human lymphocytic cell
line U937 as an in vitro cell model. We demonstrate
that exposure to 4-NP promotes proinflammatory
cytokine gene expression as an estrogen mimic, but
with considerably greater potency than estrogen
would. Thus, 4-NP modulation of proinflammatory
cytokine gene expression in lymphocytes may
dysregulate the immune system to increase
susceptibility to autoimmune disease and/or
exacerbate existing autoimmune conditions. 
Material and methods
Microarray analysis
Cell culturing 
U937 histiocytic lymphocytes (ATCC, USA) were
cultured in RPMI1640 media (Invitrogen, USA) in
six-well plates. U937 cells mature into lymphocytes
when subjected to immune stress. The U937 cell
line was selected based on its ability to be estrogen-
responsive and express both proinflammatory and
anti-inflammatory cytokine genes [24]. Cells were
kept in a 37°C incubator (NAPCO) in 5% CO2/95%
air. Experimental procedures were performed under
a sterile, laminar airflow hood. Cells were divided
into three groups and treated accordingly: 1) control
(left untreated), 2) 5 micromolar (µM) estrogen (E2),
and 3) 5 µM 4-NP . These concentrations were
chosen in order to compare the effects of naturally
occurring estrogen to two different concentrations
(high vs. low) of 4-NP . The estrogen and 4-NP
solutes were obtained from Sigma-Aldrich (St. Louis,
MO) and then diluted in methanol. 
Isolation of total mRNA
After 48 h incubation, the cells were detached
from the plate, transferred to a 15 ml tube, and
pelleted via centrifugation. Pelleted cells were
homogenized with RLT buffer by passing the cell
lysate through a 1000 µl pipette tip. RNA from the
cells was then isolated using the RNeasy Protect
Mini Kit (Qiagen, Stanford, CA) and by following
manufacturer’s protocol. RNA was eluted with 
50 µl of RNAse-DNAse-free water by centrifugation
for 1 min at 10,000 rpm.
Applied Biosystems Expression Microarray
Analysis
DNA microarray is a state of the art technique
that allows scientists to examine the effect of any
environmental agent on tens of thousands of gene
expressions at once. The quality of the RNA was
analyzed on a model 2100 bioanalyzer (Agilent,
Santa Clara, CA) using a total RNA nanochip
following the manufacturer’s protocol. Then, using
the Applied Biosystems Chemiluminescent RT-IVT
Labeling Kit version 2.0 and manufacturer’s protocol,
Digoxigenin-UTP labeled cRNA was generated and
linearly amplified from 1 µg of total mRNA. Three
chips, one for each group, each used 15 µg of
labeled cRNA and were hybridized at 55°C for 19 h
using the Applied Biosystems Chemiluminescence
Detection Kit and Applied Biosystems 1700
Chemiluminescent Microarray Analyzer following
the manufacturer’s protocol. Following hybridization,
Applied Biosystems 1700 Expression System
software was utilized to extract chemiluminescence
values from each of the three microarray images.
Experiment microarray showed that U937 cells
expressed 14,913 genes (out of 33,155 possible
genes). 
Data from the four microarray whole-genome
chips was analyzed using the Spotfire software from
TIBCO (Palo Alto, CA). The fold changes wereArch Med Sci 3, June / 2010 323
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measured by dividing the signals of the three
variables by the control signal. The control signal
served as the normalizing baseline for each of the
other three chips. A fold change of +3 or more was
considered significant dysregulation. Data was
graphically represented via Excel. 
Semi-quantitative reverse transcription-
polymerase chain reaction 
In order to support accuracy of the data of the
microarray analysis, a conventional reverse
transcription-polymerase chain reaction (RT-PCR)
was performed for the interleukin-(IL)-8Rβ gene.
This represents a conventional validation step. The
IL-8Rβ gene was selected via random selection to
ensure an un-biased decision. Primer sequences
utilized were: 5’ CCA GCC TGC TAT GAG GAC AT-3’
(IL-8RB forward), and 5’GAA TCT CGG TGG CAT CCA
GAG-3’ (IL-8Rβ reverse). An RT-PCR was also
performed for the β-actin gene which served as
a reference gene to ensure accuracy of the RT-PCR
and to normalize the results for the variable
treatments. The primer sequences utilized were: 
5’ TGA CGG GGT CAC CCA CAC TGT GCC CAT CTA-3’
(β-actin forward), and 5’ CTA GAA GCA TTG CGG
TGG ACG ATG GAG GG-3’ (β-actin reverse). 
Some RNA that was collected to run the
microarray was saved and utilized in this RT-PCR.
Total RNA concentration was standardized for RT
using a spectrophotometer. Using Invitrogen
reagents and manufacturer’s protocol, the RT and
PCR were carried out in a GeneAmp Thermocycler
PCR System 9700 (P .E. Applied Biosystems). The PCR
products were then run on a 2% Agarose gel
stained with ethidium bromide (Sigma-Aldrich) in
Tris-Borate-EDTA buffer (TBE). The gel was then
analyzed using a UV Transilluminator (UVP) and
GelPro Analyzer Software (Media Cybernetics, Silver
Spring, MD). 
Lower exposures to 4-nonylphenol
Cell culturing/RNA isolation/reverse
transcription-polymerase chain reaction
A six-well plate of U937 histiocytic lymphocytes
was cultured in RPMI1640 media. Cells were divided
into six groups, and treated accordingly: 1) control
(left untreated), 2) 1 nanomolar (nM) 4-NP, 3) 3 nM
4-NP, 4) 5 nM 4-NP, 5) 10 nM 4-NP, and 6) 50 nM
4-NP . Cells were incubated for 48 h. Total RNA was
isolated following above-mentioned protocol. An
RT-PCR was run to analyze the effect of these
extremely low, nanomolar-level concentrations of
4-NP on interleukin (IL)-8Rβ expression. An RT-PCR
was also performed for β-actin, which served as
a reference gene and normalizer for the variables.
The PCR products were run on a 2% agarose gel
stained with ethidium bromide, and analyzed via
GelPro Analyzer software.
Statistical analysis
Statistical analysis for the microarray trials 
(n = 2 for each gene) and the conventional RT-PCRs
(n = 3 each) was done using an ANOVA test
followed by a post-HOC Sheffe test. Values of 
p < 0.05 were considered significant. 
Reagents 
PCR reagents (10× buffer, 50 µM MgCl2, TAQ
polymerase, custom primers) and RT reagents
(Superscript enzyme, 5× First Strand Buffer, 0.1 M
dithiothreitol (DTT), Random Primers) were
purchased from Invitrogen, USA, and stored 
at –20°C. Phosphate-buffered saline (PBS) was also
purchased from Invitrogen, USA, and stored at room
temperature. Nucleotides (dNTPs) were purchased
from Amershar Pharmacia Biotech, USA, and stored
at –20°C. RNeasy RNA Isolation reagents and
columns were purchased from Qiagen, USA.
Electrophoresis-grade agarose was purchased from
Fisher Biotech, USA, and was stored at room
temperature. Ethidium bromide (EtBr), the gel stain,
was purchased from Sigma-Aldrich, USA.
Results
U937 cells exposed to 4-NP showed an increased
expression of all 123 DNA microarray-detected pro
inflammatory  cytokine genes. Significant  up
regulation (p < 0.05, ANOVA) was seen for: inter  -
leukin-1 (IL-1), IL-5, IL-6, IL-17C, IL-23α, interleukin-
8-receptor-β (IL-8Rβ), and interleukin-1-receptor-
associated-kinase (IRAK2) (Figure 1). Microarray
revealed that estrogen (E2) treated cells also
displayed increased pro inflammatory cytokine gene
expression, although insignificant compared to 
4-NP’s effects (Figure 1). Thus, the microarray data
supports 4-NP’s immunomodulatory role and also
that it appears to be more toxic than naturally
occurring estrogen, since it elicits effects up to 
4 times greater than estrogen does. 
Tumor necrosis factors are a class of pro-
inflammatory cytokines that act via tumor-necrosis-
factor-receptors (TNFRs) in influencing endothelial
cells vascular permeability, which impacts infection
sites (National Cancer Institute, 09). Autoimmune
diseases have been characterized as an over-
expression of TNFRs [25]. We demonstrate that 
4-NP significantly up regulated the expression of
TNFR-5, and TNFR-10 (Figure 2). 
Toll-like receptors (TLRs) are proteins that
recognize foreign structures associated with
microbes and can activate immune cell responses
and the production of various cytokines [26]. They
usually facilitate beneficial localized inflammatory324 Arch Med Sci 3, June / 2010
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responses, but improper activation could lead to
over-production of pro-inflammatory cytokines and
possibly autoimmune diseases [27]. Out of the 
9 detected TLRs, 4-NP most significantly up regulated
TLR-6 and TLR-10 (Figure 3). Although E2 also
increased the expression of these cytokine-signaling
genes, 4-NP elicited a greater up regulation. These
data further indicate that 4-NP could elicit more
potent effects on pro inflammatory cytokine gene
regulation than naturally occurring estrogen.
Additionally, 4-NP reduced the expression of 
8 detec  ted anti-inflammatory cytokine genes (Fi  gu  -
re 4). Significant change (of at least a 3-fold change,
p < 0.05 ANOVA) was observed with the 4-NP
administration for the following cytokines: IL-4 and
IL-10. Anti-inflammatory cytokine genes (i.e. IL-4)
are considered pro-healing through their ability to
suppress pro-inflammatory cytokine production 
(i.e. that of IL-1) while up regulating the expression
of pro-inflammatory cytokine receptor antagonists
(i.e. IL-1 receptor antagonists) [28]. Our data
demonstrate that 4-NP may exacerbate auto  -
immunity by suppressing beneficial, pro-healing
gene expression (Figure 4). Interestingly, E2 
up regulated the same genes that 4-NP down
regulated, suggesting that naturally occurring E2
may be beneficial in promoting a healthy presence
of anti-inflammatory cytokines, while xenoestro  -
gens may act to exacerbate disease by decreasing
the expression of such pro-healing genes during
immune stress. 
In the “validation” RT-PCR, IL-8RB was up
regulated in U937 cells (Figure 5). This data cor  -
related to the up regulation of IL-8RB observed in
the microarray experiments. An RT-PCR for the 
β-actin reference gene was used to normalize the
results and ensure accuracy, which further
supported our observations.
The Environmental Protection Agency (EPA, 2009)
sets the environmental “safety” limit of 4-NP at 
3.1 µg/l (or parts per billion). This is the equivalent
of 3,100 nM. Since the microarrays examined the
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Figure 1. U937 cells treated with 5 µM 4-NP for 48 h
showed significantly up regulated pro-inflammatory
cytokine gene expressions, compared to control
expressions, while estrogen (E2 5 µM) elicited
insignificant effects. For IL-1, 4-NP caused a 3.451-
fold up regulation compared to control, and 4-NP
was 2.385 times more potent than E2. For IL-5, 4-NP
caused a 7.291-fold up regulation compared to
control, and 4-NP was 1.876 times more potent than
E2. For IL-6, 4-NP caused a 5.587-fold up regulation
compared to control, and 4-NP was 2.483 times more
potent than E2. For IL-8RB, 4-NP caused a 4.808-fold
up regulation compared to the control, and 4-NP was
1.832 times more potent than E2. For IRAK-2, 4-NP
caused a 9.161-fold up regulation compared to
control, and 4-NP was 2.305 times more potent than
E2. For IL-17C, 4-NP caused a 3.856-fold up regulation
compared to the control, and 4-NP was 1.402 times
more potent than E2. For IL-23A, 4-NP caused 
a 7.185-fold up regulation compared to the control,
and 4-NP was 1.892 times more potent than E2
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Figure 3. 4-Nonylphenol 5 µM caused significant up
regulation of TLR-6 and TLR-10. For TLR-6, 4-NP
caused a 5.587-fold up regulation compared to the
control, and 4-NP was 2.483 times more potent than
E2. For TLR-10, 4-NP caused an 8.760-fold up
regulation compared to the control, and 4-NP was
2.802 times more potent than E2
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Figure 2. 4-Nonylphenol 5 µM caused significant up
regulation of TNFR-5 and TNFR-10. For TNFR-5, 4-NP
caused a 5.137-fold up regulation compared to the
control, and 4-NP was 3.545 times more potent than
E2. For TNFR-10, 4-NP caused a 10.992-fold up
regulation compared to the control, and 4-NP was
3.433 times more potent than E2Arch Med Sci 3, June / 2010 325
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effect of 4-NP at relatively high, micromolar-level
concentrations, an experiment was run to examine
whether 4-NP could elicit effects at even lower,
nanomolar (nM), concentrations. The data in Figure 6,
however, shows that 4-NP is capable of eliciting
effects on the immune system at 1 nM, although
these effects are not statistically significant. Indeed,
an up regulation of IL-8Rβ was seen even at the
lowest observed concentration of 4-NP, 1 nM. This
may suggest that 4-NP is capable of altering human
immunity, a speculation that requires greater
sample size.
Discussion
This report demonstrates that the ubiquitous
environmental toxin 4-NP may be a contributing
factor in the development of immune-type disease
as noted by its enhancement of proinflammatory
cytokine gene expression in U937 cells. In this
regard it exhibits estrogenic properties. Specifically,
4-NP induced a 3.451-fold up regulation of IL-1 as
compared to the controls. 4-Nonylphenol also
caused a 9.161-fold up regulation of the expression
of IRAK-2. Since IL-1 is an important regulator of
lymphocyte differentiation and the inflammatory
response, an abnormal up regulation of IL-1 and/or
IRAK-2 may contribute to increased inflammation.
4-NP elicited a 7.291-fold up regulation of IL-5,
stimulator of β cell growth, compared to the control.
4-Nonylphenol also induced a significant increase
in the expression of IL-6, IL-8Rβ, IL-17C, and IL-23A
(Figure 1). Additionally, the TNFRs were also
significantly up regulated by 4-NP . Since
autoimmune diseases can be characterized by over-
expression of TNFRs and TLRs [25-27], this data
supports 4-NP as a contributor to increasing
autoimmune disease risk. 
It was also demonstrated that estrogen (E2)
elicited a similar up regulation of these same pro
inflammatory cytokine genes but to a lesser degree
than 4-NP . 4-Nonylphenol up regulated IL-1
expression 2.385 times more that E2 did and 4-NP
was 1.876 times more potent in up regulating IL-5
than E2. This trend continues for IL-6, IL-8Rβ, 
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Figure 4. At the same time, 4-NP 5 µM caused
significant down-regulation of anti-inflammatory
cytokine genes – IL-4 and IL-10. For IL-4, 4-NP caused
a significant 3.680-fold down regulation compared
to control, while E2 caused an insignificant 1.176 fold
up regulation compared to the control. For IL-10, 
4-NP caused a significant 5.903-fold down regulation
compared to the control, while E2 caused an
insignificant 1.923 fold up regulation compared to
the control
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Control  E2 5 µM 4-NP 5 µM
Figure 5. This figure depicts the results from the
conventional RT-PCR for the IL-8Rβ gene, which
served as the validation for our microarray. Fold
change was obtained by dividing the photometric
measure (determined by GelPro Analysis software)
of each variable by the control signal. These figures
were then normalized with the results of the β-actin
signals. While E2 5 µM caused an insignificant up
regulation of IL-8Rβ 1.536 times greater than control
expression, 4-NP 5 µM caused a significant 2.555-
fold up regulation compared to the control. These
data correlate to the up-regulation of IL-8Rβ seen in
the microarray data, thus we demonstrate that all
other microarray data is accurate
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Figure 6. This graph depicts the effect of 4-NP at
extremely low, nanomolar concentrations on IL-8Rβ
gene expression. 4-NP caused a concentration-
dependent up regulation of IL-8Rβ. Fold change was
normalized with the results of the β-actin signals. At
1 nM, 4-NP caused a 0.371 fold up regulation. At 
3 nM, there was a 0.395 fold up regulation. At 5 nM,
there was a 0.405 fold up regulation. At 10 nM, there
was a 0.526 fold up regulation. At 50 nM, there was
a 0.702 fold up regulation
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IRAK-2, IL-17C, and IL-23A, where 4-NP elicits an up
regulation 2.483, 2.802, 1.832, 2.305, 1.402, and 1.892
times greater than E2, respectively. This supports
the hypothesis that 4-NP is more toxic than
naturally occurring estrogen in regard to disturbing
the immune response, because 4-NP elicits a more
potent dysregulation of the proinflammatory
cytokine gene expression.
Importantly, 4-NP was also shown to significantly
down regulate the expression of beneficial, pro-
healing, anti-inflammatory cytokine gene
expression. 4-Nonylphenol elicited a 3.477-fold
down regulation of IL-4. Interleukin-4 has been
shown to suppress IL-1 production [26]. Thus, 4-NP
may increase immune malfunction by decreasing
the expression of the beneficial IL-4 gene that acts
to reduce harmful, proinflammatory IL-1 production.
4-Nonylphenol also caused a 5.903 fold down
regulation of the anti-inflammatory cytokine, IL-10.
This gene is known to counteract inflammatory
responses and is also capable of suppressing the
synthesis of certain pro-inflammatory cytokines
[29]. Therefore, a down regulation of this beneficial
gene may lead to an increased synthesis of
proinflammatory cytokines, contributing to
increased autoimmune risk. 
Estrogen’s effect on the same anti-inflammatory
cytokine genes is opposite to the effect of 4-NP .
Although there is no significant up regulation by
estrogen, the data is thought provoking, suggesting
that industrial estrogens like 4-NP may play a more
adverse role in the risk of developing immune
disease than naturally occurring estrogens.
In conclusion, since the EPA sets a “safe”
environmental exposure limit of 4-NP at 3.1 µg/l =
3.1 parts per billion our results in tissue culture
reveal that this level have to be adjusted. 
For example, although the up regulation of
proinflammatory IL-8Rβ with the various 4-NP
administrations ranging from 1 nM ~ 50 nM is
insignificant (p > 0.05 ANOVA, n = 3), it is still clear
that at concentrations far below the EPA’s “safe”
limit, 4-NP can still up regulate the proinflammatory
cytokine gene.
The current project demonstrates the following:
1) 4-NP significantly up regulates proinflammatory
cytokine gene expression in U937 cells, 2) estrogen
causes a similar but less marked increase in
proinflammatory cytokine gene expression, 3) 4-NP
may pose greater risk to the immune-prone
individuals by eliciting effects up to 4 times greater
than estrogen, 4) 4-NP disturbs cytokine gene
expression at concentrations far below the EPA
limit.
It is interesting that E2 can have varied effects,
some beneficial and others detrimental [30-33]. The
negative effects may be linked to abnormal
regulation of nitric oxide production, release and/or
degradation. A similar story exists for endogenous
morphine and its related phenomena, for example,
tolerance and addiction [34-40]. In considering this
hypothesis one is drawn to the ability of
constitutive nitric oxide to modulate mitochondrial
function [36, 41]. The full development of this
hypothesis is presently under our focus. 
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